Dr. Charles A Thornton MD
Neurologist | Vascular Neurology
601 Elmwood Ave Box 278984 Rochester NY, 14642About
Dr. Charles Thornton is a distinguished Neurologist in Rochester, NY. Dr. Thornton specializes in diagnosing, treating, and managing disorders of the brain and nervous system. With expertise in handling complex conditions like epilepsy, multiple sclerosis, and migraines, Dr. Thornton employs advanced techniques and personalized treatment plans to improve patient outcomes. As a neurologist, Dr. Thornton is committed to staying abreast of the latest developments in neurological research and therapies.
Education and Training
Univ Of Ia Coll Of Med- Iowa City Ia 1981
University of Ia Roy J & L Carver Com 1981
Baylor College of Medicine, Houston, Texas 1981
Board Certification
Psychiatry and NeurologyAmerican Board of Psychiatry and NeurologyABPN
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy.
- Computational method for reducing variance with Affymetrix microarrays.
- Myotonic syndromes.
- Molecular fingerprints of inflammatory myopathies.
- Reduced amount of mitochondrial DNA in aged human muscle.
- Gene expression profile of aging in human muscle.
- A muscleblind knockout model for myotonic dystrophy.
- Ribonuclear inclusions in skeletal muscle in myotonic dystrophy types 1 and 2.
- Skeletal muscle gene expression profiles in 20-29 year old and 65-71 year old women.
- Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons.
- Truncated ClC-1 mRNA in myotonic dystrophy exerts a dominant-negative effect on the Cl current.
- Nuclear RNA foci in the heart in myotonic dystrophy.
- Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy.
- Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy.
- RNA-dominant diseases.
Treatments
- Muscular Dystrophy
- Amyotrophic Lateral Sclerosis (als)
Professional Memberships
- Fellow 2005- American Academy of Neurology
- Member Scientific Advisory Board, Senator Paul D Wellstone Muscular Dystrophy Cooperative Research Center 2006
- Member American Society of Gene Therapy 2008
Dr. Charles A Thornton MD's Practice location
Rochester, NY 14642Get Direction
Dr. Charles A Thornton MD's reviews
Write ReviewPatient Experience with Dr. Thornton
Recommended Articles
- Denture Creams Can Cause Nerve Damage
A number of recent reports show that overuse of denture creams and other products leads to nerve damage. The major reason behind this damage is zinc poisoning from the products. Zinc is an important mineral required by the body, but the amount of zinc is usually balanced with that of copper. People...
- Multiple Sclerosis: The Center Without Walls Program
The Center Without Walls program is there to support the medical community in working together to further the information and research available in the fight against multiple sclerosis, and Nancy Davis has been a crucial element.Nancy's storyNancy Davis has always lived a very full life. In Denver,...
- What is Dyslexia?
Dyslexia refers to a disorder characterized by disability in reading. This is a very common learning disability and is found to affect a large percentage of people in the country. Children with this learning disorder are found to have normal vision and intelligence. In many cases, the condition...
- Aricept for Alzheimer's Disease: Side Effects and Usage
Generic Name: DonepezilBrand Names: Aricept, Aricept ODTWhat is Aricept?Aricept (donepezil) is a medication used for the treatment of mild to moderate dementia due to Alzheimer's disease. This medication improves nerve function in the brain and works by preventing the breakdown of acetylcholine,...
- The History of Lobotomy
Lobotomy is now considered an inhumane and obsolete procedure that no one would ever want to be subjected to. However, at the time of its advent, it was not the primitive and brutal surgery we view it as today. In a time where medications to treat psychological and emotional conditions were...
- New Multiple Sclerosis Treatment, Ocrevus, Slows Down Disease Progression
In 2017, the United States Food and Drug Administration (USFDA) approved the drug – Ocrevus (ocrelizumab) – as a treatment for both relapsing and progressive forms of multiple sclerosis. ...
Nearby Providers
- Dr. James Azurin MD MS2101 Lac Deville Boulevard Rochester NY 14618
- Dr. I-hweii Amy Chen MD1425 Portland Ave Rochester NY 14621
- David J Gill Other2655 Ridgeway Ave Rochester NY 14626
- Dr. Harold D Lesser MD101 SULLYS TRL PITTSFORD NY 14534
- Dr. Natan Khishchenko MD2655 Ridgeway Ave Rochester NY 14626
- Dr. Michel J Berg MD601 Elmwood Ave Rochester NY 14642